*/
Rachel Davenport, Co-founder and Director at AlphaBiolabs, discusses the role that drug, alcohol and DNA testing can play in non-court dispute resolution (NCDR)
Changes to the Family Procedure Rules in relation to NCDR, which came into force in April 2024, marked a transformative moment for family law professionals and mediation practices in the UK.
Designed to strengthen the role of mediation by placing emphasis on non-adversarial approaches and broadening the definition of NCDR to include a wide range of methods for dispute resolution, the rules seek to empower families to resolve conflicts constructively, with minimal court intervention.
However, the success of mediation often depends on the trust and cooperation of all parties. In cases involving allegations of substance misuse or disputes over biological relationships, impartial evidence provided by drug, alcohol and DNA testing can help to:
For counsel involved in family law, mediation and child welfare, impartial evidence from drug, alcohol and DNA testing has become an indispensable tool for facilitating informed decisions.
Drug, alcohol and/or DNA testing may be sought during NCDR for a variety of reasons including:
The results of these tests can provide legal practitioners with concrete evidence needed to navigate disputes, strengthen mediation outcomes, and meet court-mandated evidence standards when NCDR is pursued.
Concerns surrounding a parent’s suspected substance misuse can heavily impact mediation where the issues of childcare and visitation are central to discussions. In these circumstances, drug and alcohol tests offer impartial evidence as to whether or not there has been recent or longer-term substance misuse.
Options for testing include:
These methods ensure that decisions about parenting arrangements can be made based on objective evidence, prioritising the child/children’s welfare.
Uncertainty surrounding a child’s parentage can cause significant emotional strain during mediation, leading to emotionally-charged discussions that dominate proceedings.
In these circumstances, DNA testing such as paternity testing or non-invasive prenatal paternity testing – which can be performed from as early as 7 weeks into pregnancy, and is completely risk-free for mum and baby – can offer a simple, accurate and reliable way of confirming a child’s parentage.
This can allow separating families to reach decisions more quickly regarding visitation and custody arrangements, as well as financial support.
The NCDR rules highlight the importance of open communication and co-operation in resolving family disputes, and helping families to reach agreements based on trust and clarity.
Whether testing is required to ensure a child’s safety or to confirm a biological relationship, AlphaBiolabs can help.
We have over 20 years’ experience providing drug, alcohol and DNA testing for legal and official matters, including as part of NCDR.
We also provide rapid results from our UKAS 17025-acredited UK laboratory, with all testing performed in the UK – so samples are never sent abroad.
For more information contact our New Enquiry team on 0333 600 1300 / testing@alphabiolabs.com or visit https://www.alphabiolabs.co.uk/legal-test-forms/, and we will be happy to discuss the requirements of your case.
Changes to the Family Procedure Rules in relation to NCDR, which came into force in April 2024, marked a transformative moment for family law professionals and mediation practices in the UK.
Designed to strengthen the role of mediation by placing emphasis on non-adversarial approaches and broadening the definition of NCDR to include a wide range of methods for dispute resolution, the rules seek to empower families to resolve conflicts constructively, with minimal court intervention.
However, the success of mediation often depends on the trust and cooperation of all parties. In cases involving allegations of substance misuse or disputes over biological relationships, impartial evidence provided by drug, alcohol and DNA testing can help to:
For counsel involved in family law, mediation and child welfare, impartial evidence from drug, alcohol and DNA testing has become an indispensable tool for facilitating informed decisions.
Drug, alcohol and/or DNA testing may be sought during NCDR for a variety of reasons including:
The results of these tests can provide legal practitioners with concrete evidence needed to navigate disputes, strengthen mediation outcomes, and meet court-mandated evidence standards when NCDR is pursued.
Concerns surrounding a parent’s suspected substance misuse can heavily impact mediation where the issues of childcare and visitation are central to discussions. In these circumstances, drug and alcohol tests offer impartial evidence as to whether or not there has been recent or longer-term substance misuse.
Options for testing include:
These methods ensure that decisions about parenting arrangements can be made based on objective evidence, prioritising the child/children’s welfare.
Uncertainty surrounding a child’s parentage can cause significant emotional strain during mediation, leading to emotionally-charged discussions that dominate proceedings.
In these circumstances, DNA testing such as paternity testing or non-invasive prenatal paternity testing – which can be performed from as early as 7 weeks into pregnancy, and is completely risk-free for mum and baby – can offer a simple, accurate and reliable way of confirming a child’s parentage.
This can allow separating families to reach decisions more quickly regarding visitation and custody arrangements, as well as financial support.
The NCDR rules highlight the importance of open communication and co-operation in resolving family disputes, and helping families to reach agreements based on trust and clarity.
Whether testing is required to ensure a child’s safety or to confirm a biological relationship, AlphaBiolabs can help.
We have over 20 years’ experience providing drug, alcohol and DNA testing for legal and official matters, including as part of NCDR.
We also provide rapid results from our UKAS 17025-acredited UK laboratory, with all testing performed in the UK – so samples are never sent abroad.
For more information contact our New Enquiry team on 0333 600 1300 / testing@alphabiolabs.com or visit https://www.alphabiolabs.co.uk/legal-test-forms/, and we will be happy to discuss the requirements of your case.
Rachel Davenport, Co-founder and Director at AlphaBiolabs, discusses the role that drug, alcohol and DNA testing can play in non-court dispute resolution (NCDR)
Chair of the Bar reports back
Marie Law, Director of Toxicology at AlphaBiolabs
A £500 donation from AlphaBiolabs has been made to the leading UK charity tackling international parental child abduction and the movement of children across international borders
Marie Law, Director of Toxicology at AlphaBiolabs, outlines the drug and alcohol testing options available for family law professionals, and how a new, free guide can help identify the most appropriate testing method for each specific case
By Louise Crush of Westgate Wealth Management
Marie Law, Director of Toxicology at AlphaBiolabs, examines the latest ONS data on drug misuse and its implications for toxicology testing in family law cases
A career shaped by advocacy beyond her practice, and the realities of living with an invisible disability – Dr Natasha Shotunde, Black Barristers’ Network Co-Founder and its Chair for seven years, reflects on a decade at the Bar
The odds of success are as unforgiving as ever, but ambition clearly isn’t in short supply. David Wurtzel’s annual deep‑dive into the competition cohort shows who’s entering, who’s thriving and the trends that will define the next wave
Where to start and where to find help? Monisha Shah, Chair of the King’s Counsel Selection Panel, provides an overview of the silk selection process, debunking some myths along the way
Do chatbot providers owe a duty of care for negligent misstatements? Jasper Wong suggests that the principles applicable to humans should apply equally to machines
There is no typical day in the life as a Supreme Court judicial assistant, says Josephine Gillingwater, and that’s what makes the role so enjoyably diverse